MedPath

Virtual Reality Education Module in Reducing Anxiety and Increasing Knowledge in Patients With Prostate Cancer Undergoing Radiation Therapy

Not Applicable
Terminated
Conditions
Prostate
Interventions
Other: Educational Intervention
Registration Number
NCT03318367
Lead Sponsor
Sidney Kimmel Cancer Center at Thomas Jefferson University
Brief Summary

This pilot clinical trial studies a virtual reality education module in reducing anxiety and increasing knowledge in patients with prostate cancer undergoing radiation therapy. A virtual reality education module may be useful in helping patients understand what they can expect to happen during their radiation treatments and help reduce stress relating to the radiation treatments.

Detailed Description

PRIMARY OBJECTIVES:

I. To determine if a virtual reality education module for prostate cancer patients is effective in increasing patient comprehension and decreasing patient anxiety related to radiation treatments.

SECONDARY OBJECTIVES:

I. This pilot study could have implications for a broader patient base undergoing radiation therapy.

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
23
Inclusion Criteria
  • English speaking males capable of giving informed consent
  • Must be able to read English language
  • Receiving pre-treatment cone beam and volumetric modulated arc therapy (VMAT) for prostate cancer on the "A" or "B" treatment machines at the Bodine Center
  • Must be able to walk two city blocks
  • Must not have any auditory or visual deficits
Read More
Exclusion Criteria
  • If inclusion criteria are not met
  • Previous radiation therapy treatment
  • Employment in radiation oncology
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Supportive care (virtual reality education module)Educational InterventionAfter undergoing a previously planned CT simulation scan, patients complete a virtual reality education module to learn more about radiation therapy for prostate cancer. Patients also complete questionnaires before and after the module.
Primary Outcome Measures
NameTimeMethod
Standard deviation for difference in questionnaire response from pre-education to post-educationThrough study completion, an average of 2 years

A one-sided one-sample t-test will be used to analyze the average change score (pre - post) for each questionnaire.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath